test

IncobotulinumtoxinA for Treatment of Focal Cancer Pain After Surgery and/or Radiation

Conditions

Ill-Defined Sites | Pain

What is the purpose of this trial?

The purpose of this research study is to investigate the safety and effectiveness of botulinum toxin A (Xeomin) ® injections in patients who suffer from focal pain in areas of radiation and/or surgery as a result of cancer treatment. Our hypothesis is that injection of incobotulinum toxin A into an area of local pain, at or around the area of a post-surgical/post radiation scar, relieves the focal cancer pain.


Participation Guidelines

Age:
18 Years - 80 Years
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
Merz Pharmaceuticals
Dates:
09/07/2012
Last Updated:
Study HIC#:
1205010328